Prolonged Use of GLP-1 Receptor Agonists May Increase the Risk for a Serious Eye Condition

Posted June 6, 2025

People with diabetes who use GLP-1 receptor agonists like semaglutide are more likely to develop neovascular age-related macular degeneration, a new study finds.

Health News is provided as a service to Diabetes Resource Centre site users by HealthDay. Diabetes Resource Centre nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Get Healthy!

Prolonged Use of GLP-1 Receptor Agonists May Increase the Risk for a Serious Eye Condition

Copyright © 2025 HealthDay All Rights Reserved.

Tags

Patient Resources

Get Healthy!

Prolonged Use of GLP-1 Receptor Agonists May Increase the Risk for a Serious Eye Condition

Copyright © 2025 HealthDay All Rights Reserved.

Share

Tags